HC Wainwright & Co. Maintains Buy on Akerna, Lowers Price Target to $5
HC Wainwright & Co. analyst Scott Buck maintains Akerna (NASDAQ:KERN) with a Buy and lowers the price target from $7 to $5.
‘Virginia Election Outcome Endangers Marijuana Legalization Rollout’ -Marijuana Moment
https://www.marijuanamoment.net/virginia-election-outcome-endangers-marijuana-legalization-rollout/
Akerna’s Stock Slightly Up On Announcing 38% YoY Increase In Q3 Revenue
Cannabis software company Akerna Corp. (NASDAQ: KERN) reported its unaudited financial results Monday for the quarter ended September 30, with software revenue spiking 37% year-over-year to $4.6 million.
Akerna Q3 Sales $5.10M Miss $5.13M Estimate
Akerna (NASDAQ:KERN) reported quarterly sales of $5.10 million which missed the analyst consensus estimate of $5.13 million by 0.58 percent. This is a 66.07 percent increase over sales of $3.07 million the same period
11 Industrials Stocks Moving In Friday’s After-Market Session
Gainers
Akerna (NASDAQ:KERN) stock increased by 3.08% to $2.67 during Friday's after-market session. The company's market cap stands at $81.8 million.
‘South Dakota Marijuana Activists Delay Legalization Signature Delivery After Missing Initial Deadline’ -Marijuana Moment Report
https://www.marijuanamoment.net/south-dakota-marijuana-activists-delay-legalization-signature-delivery-after-missing-initial-deadline/
‘Another Poll Shows Marijuana Support For Marijuana Legalization, Including Most Republicans’ -Marijuana Moment Report
https://www.marijuanamoment.net/another-poll-shows-marijuana-support-for-marijuana-legalization-including-most-republicans/
‘Bill On Studying Marijuana From Dispensaries Heads To Biden’s Desk After Congressional Passage’ -Marijuana Moment Report
https://www.marijuanamoment.net/bill-on-studying-marijuana-from-dispensaries-heads-to-bidens-desk-after-congressional-passage/</
Earnings Scheduled For November 8, 2021
Companies Reporting Before The Bell
• Privia Health Group (NASDAQ:PRVA) is projected to report quarterly loss at $0.11 per share on revenue of $215.14 million.
The Week In Cannabis: Canopy’s Earnings, JPMorgan’s Restrictions, A Slew Of Earnings, Big Policy Moves
Below is a recap of the main news related to the cannabis industry and markets for the week of November 1st, 2021.
Contents